These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 30841919)

  • 21. The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis.
    Xu K; Tian X; Oh SY; Movassaghi M; Naber SP; Kuperwasser C; Buchsbaum RJ
    Breast Cancer Res; 2016 Jan; 18(1):14. PubMed ID: 26821678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile.
    Berthelet J; Wimmer VC; Whitfield HJ; Serrano A; Boudier T; Mangiola S; Merdas M; El-Saafin F; Baloyan D; Wilcox J; Wilcox S; Parslow AC; Papenfuss AT; Yeo B; Ernst M; Pal B; Anderson RL; Davis MJ; Rogers KL; Hollande F; Merino D
    Sci Adv; 2021 Jul; 7(28):. PubMed ID: 34233875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The bone microenvironment invigorates metastatic seeds for further dissemination.
    Zhang W; Bado IL; Hu J; Wan YW; Wu L; Wang H; Gao Y; Jeong HH; Xu Z; Hao X; Lege BM; Al-Ouran R; Li L; Li J; Yu L; Singh S; Lo HC; Niu M; Liu J; Jiang W; Li Y; Wong STC; Cheng C; Liu Z; Zhang XH
    Cell; 2021 Apr; 184(9):2471-2486.e20. PubMed ID: 33878291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts.
    Lefley D; Howard F; Arshad F; Bradbury S; Brown H; Tulotta C; Eyre R; Alférez D; Wilkinson JM; Holen I; Clarke RB; Ottewell P
    Breast Cancer Res; 2019 Nov; 21(1):130. PubMed ID: 31783893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping the transcriptional evolution of human metastatic breast cancer.
    Reeves MQ
    J Clin Invest; 2024 Sep; 134(17):. PubMed ID: 39225091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecularly annotation of mouse avatar models derived from patients with colorectal cancer liver metastasis.
    Wang J; Xing B; Liu W; Li J; Wang X; Li J; Yang J; Ji C; Li Z; Dong B; Gao J; Shen L
    Theranostics; 2019; 9(12):3485-3500. PubMed ID: 31281492
    [No Abstract]   [Full Text] [Related]  

  • 27. Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches.
    Hebert JD; Myers SA; Naba A; Abbruzzese G; Lamar JM; Carr SA; Hynes RO
    Cancer Res; 2020 Apr; 80(7):1475-1485. PubMed ID: 32019869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic pathways modulated by Twist in breast cancer.
    Vesuna F; Bergman Y; Raman V
    BMC Cancer; 2017 Jan; 17(1):52. PubMed ID: 28086829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.
    Merlino G; Miodini P; Callari M; D'Aiuto F; Cappelletti V; Daidone MG
    Mol Oncol; 2017 Oct; 11(10):1399-1412. PubMed ID: 28672102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion.
    Rhost S; Hughes É; Harrison H; Rafnsdottir S; Jacobsson H; Gregersson P; Magnusson Y; Fitzpatrick P; Andersson D; Berger K; Ståhlberg A; Landberg G
    Breast Cancer Res; 2018 Nov; 20(1):137. PubMed ID: 30454027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung metastases share common immune features regardless of primary tumor origin.
    García-Mulero S; Alonso MH; Pardo J; Santos C; Sanjuan X; Salazar R; Moreno V; Piulats JM; Sanz-Pamplona R
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32591432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Splenectomy reduces lung metastases and tumoral and metastatic niche inflammation.
    Stöth M; Freire Valls A; Chen M; Hidding S; Knipper K; Shen Y; Klose J; Ulrich A; Ruiz de Almodovar C; Schneider M; Schmidt T
    Int J Cancer; 2019 Nov; 145(9):2509-2520. PubMed ID: 31034094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCL17-derived CD11b
    Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
    Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A taxonomy of organ-specific breast cancer metastases based on a protein-protein interaction network.
    Sanz-Pamplona R; García-García J; Franco S; Messeguer X; Driouch K; Oliva B; Sierra A
    Mol Biosyst; 2012 Aug; 8(8):2085-96. PubMed ID: 22710377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung.
    Tawara K; Bolin C; Koncinsky J; Kadaba S; Covert H; Sutherland C; Bond L; Kronz J; Garbow JR; Jorcyk CL
    Breast Cancer Res; 2018 Jun; 20(1):53. PubMed ID: 29898744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
    Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
    Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Mechanisms of Breast Cancer Metastasis to the Lung: Clinical and Experimental Perspectives.
    Medeiros B; Allan AL
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31071959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis-Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer.
    Kimbung S; Johansson I; Danielsson A; Veerla S; Egyhazi Brage S; Frostvik Stolt M; Skoog L; Carlsson L; Einbeigi Z; Lidbrink E; Linderholm B; Loman N; Malmström PO; Söderberg M; Walz TM; Fernö M; Hatschek T; Hedenfalk I;
    Clin Cancer Res; 2016 Jan; 22(1):146-57. PubMed ID: 26276891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models.
    Gómez-Miragaya J; Morán S; Calleja-Cervantes ME; Collado-Sole A; Paré L; Gómez A; Serra V; Dobrolecki LE; Lewis MT; Diaz-Lagares A; Eroles P; Prat A; Esteller M; González-Suárez E
    Mol Cancer Res; 2019 Oct; 17(10):2063-2076. PubMed ID: 31320385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse.
    Harrell JC; Prat A; Parker JS; Fan C; He X; Carey L; Anders C; Ewend M; Perou CM
    Breast Cancer Res Treat; 2012 Apr; 132(2):523-35. PubMed ID: 21671017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.